Studies have reported that Met can inhibit cellular inflammatory response by inhibiting the NF-κB signaling pathway [39], improve alveolar bone healing by increasing osteoblast differentiation in patients [40], and induce antibacterial effects against P. gingivalis in diabetes-related periodontitis [27]. Here, NFKB1 is linked to diabetes mellitus.